Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Merrimack Pharmaceuticals, Inc. (MACK)

12.52   0.15 (1.21%) 09-27 16:00
Open: 12.41 Pre. Close: 12.37
High: 12.53 Low: 12.36
Volume: 18,904 Market Cap: 179(M)

Technical analysis

as of: 2023-09-27 4:20:39 PM
Short-term rate:       
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Mid-term rate:       
Target: Six months: 14.65     One year: 17.12
Support: Support1: 12.2    Support2: 11.98
Resistance: Resistance1: 12.55    Resistance2: 14.65
Pivot: 12.29
Moving Average: MA(5): 12.34     MA(20): 12.28
MA(100): 12.26     MA(250): 11.07
MACD: MACD(12,26): 0     Signal(9): 0
Stochastic oscillator: %K(14,3): 88.7     %D(3): 75
RSI: RSI(14): 63.7
52-week: High: 13.65  Low: 3
Average Vol(K): 3-Month: 62 (K)  10-Days: 32 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
[ MACK ] has closed above the upper band by 15.6%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 43.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 17 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 12.54 - 12.57 12.57 - 12.62
Low: 12.25 - 12.29 12.29 - 12.34
Close: 12.44 - 12.51 12.51 - 12.59

Company Description

Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.

Headline News

Tue, 26 Sep 2023
Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) most popular amongst retail investors who own 39% of the shares, institutions hold 33% - Yahoo Finance

Mon, 25 Sep 2023
Seattle cop put on leave after hurling anti-Asian, sexist slurs at neighbor - Yahoo News

Mon, 25 Sep 2023
Fla. Man Charged After Toddler Shoots, Injures Herself With Gun He Allegedly Left Out - Yahoo Entertainment

Tue, 19 Sep 2023
Pancreatic Cancer Battle Boosted by $200M VC Firm - PR Newswire

Fri, 04 Aug 2023
Is SM Energy Company's (NYSE:SM) Stock's Recent Performance Being Led By Its Attractive Financial Prospects? - Yahoo Finance

Thu, 03 Aug 2023
Merrimack Reports Second Quarter 2023 Financial Results - Business Wire

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. 14 (M)
Shares Float 10 (M)
% Held by Insiders 1.2 (%)
% Held by Institutions 52.9 (%)
Shares Short 1,070 (K)
Shares Short P.Month 1,080 (K)

Stock Financials

EPS -0.11
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 1.33
Profit Margin (%) 0
Operating Margin (%) 0
Return on Assets (ttm) -8.5
Return on Equity (ttm) -9.8
Qtrly Rev. Growth 0
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) 0
Qtrly Earnings Growth 0
Operating Cash Flow -1 (M)
Levered Free Cash Flow -1 (M)

Stock Valuations

PE Ratio -113.82
PEG Ratio 0
Price to Book value 9.41
Price to Sales 0
Price to Cash Flow -121.97

Stock Dividends

Dividend 0.5
Forward Dividend 0
Dividend Yield 3.9%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.